The Relationship Between Healthcare Spending And Gross Domestic Product: A Study From A Sample Of African Countries by Addo, Steven Harrington
Wayne State University
Wayne State University Dissertations
1-1-2016
The Relationship Between Healthcare Spending
And Gross Domestic Product: A Study From A
Sample Of African Countries
Steven Harrington Addo
Wayne State University,
Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations
Part of the Economics Commons, and the Medicine and Health Sciences Commons
This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in
Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Addo, Steven Harrington, "The Relationship Between Healthcare Spending And Gross Domestic Product: A Study From A Sample Of
African Countries" (2016). Wayne State University Dissertations. 1614.
http://digitalcommons.wayne.edu/oa_dissertations/1614
	THE RELATIONSHIP BETWEEN HEALTHCARE SPENDING AND 
GROSS DOMESTIC PRODUCT: A STUDY FROM A SAMPLE OF 
AFRICAN COUNTRIES 
 
by 
STEVEN H. ADDO 
DISSERTATION 
Submitted to the Graduate School 
of Wayne State University, 
Detroit, Michigan 
in partial fulfillment of the requirements 
for the degree of 
DOCTOR OF PHILOSOPHY 
2016 
                              MAJOR: ECONOMICS 
             Approved By: 
 
 
 
 
 
Advisor                                        Date 
 
 
 
	 
 
© COPYRIGHT BY 
STEVEN H. ADDO 
2016 
All Rights Reserved
		 ii	
DEDICATION 
To the loving memory of my mother, Ethel Louise Addo, without whose love, encouragement and 
support the achievement of this success would not have been possible.  To my wife, Vivian, and 
all children, for their patience, sacrifice and encouragement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 iii	
ACKNOWLEDGEMENTS 
I acknowledge the support I received from my dissertation advisor, Dr. Allen C. Goodman 
and the graduate director and member of my dissertation committee, Dr. Li Way Lee.  I can truly 
say that this dissertation would not have come to fruition without their invaluable advice and 
assistance.  For all you did to make this dissertation possible I am immensely grateful. 
I also acknowledge and thank my dissertation committee members, Dr. Kevin D. Cotter 
and Dr. Janet R. Hankin for their advice and assistance, and for agreeing to serve on my committee 
at a time of great need.  I will forever be grateful for all your kind words of encouragement. 
I acknowledge my professors, who imparted knowledge in a most selfless manner, for their 
invaluable help; and my colleagues in the Ph.D. program, who toiled and struggled with me in 
classes and workshops.  My interactions with you have greatly enriched my experience and for 
this I am appreciative. 
My family, relatives and friends have all been supportive of me throughout my time in 
graduate school.  I thank you all for your kind words of encouragement and your patience with me 
as I undertook this task. 
 
 
 
 
 
 
		 iv	
TABLE OF CONTENTS 
Dedication ....................................................................................................................................... ii 
Acknowledgements ........................................................................................................................ iii 
List of Tables ................................................................................................................................. vi 
List of Figures ............................................................................................................................... vii 
Chapter 1 Introduction ..............................................................................................................1 
1.1  Objectives and Challenges of Health Systems .........................................................1 
1.2  The Rising Costs of Healthcare ...............................................................................9 
Chapter 2 Literature Review ...................................................................................................15 
Chapter 3 A Model of Healthcare Determination ..................................................................18 
Chapter 4 Data ........................................................................................................................23 
Chapter 5 Methods and Estimation ........................................................................................24 
5.1  Tests for Stationarity ..............................................................................................24 
5.2  Test for Cointegration ............................................................................................25 
5.3 Model Estimation ...................................................................................................26 
Chapter 6 Results ....................................................................................................................30 
6.1  Results on Stationarity ...........................................................................................30 
6.2  Results on Cointegration ........................................................................................30 
6.3 Results from Model Estimation .............................................................................33 
Chapter 7 Conclusion .............................................................................................................40 
References ......................................................................................................................................43 
		 v	
Abstract ..........................................................................................................................................46 
Autobiographical Statement ...........................................................................................................48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 vi	
LIST OF TABLES 
Table 6.1     Summary Statistics ................................................................................................... 31 
Table 6.2     Country-by-Country ADF Tests and Panel IPS Test ................................................ 33 
Table 6.3     Test for Cointegration ............................................................................................... 34 
Table 6.4     Coefficient Estimates without the use of Instrumental Variables ............................. 37 
Table 6.5     Coefficient Estimates with Instrumental Variables .................................................. 38	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		 vii	
LIST OF FIGURES 
Figure 1.1     Total Healthcare Spending, by Region, 1995 – 2014	..............................................	10	
Figure 1.2     Total Healthcare Spending as a Share of GDP, by Region, 1995 – 2014	...............	11	
Figure 1.3     Growth of Total Healthcare Spending as a Share of GDP 
               by Region, 1995 – 2014	..........................................................................................	12	
Figure 1.4     General Government Health Expenditures as a Share of General 
               Government Expenditures, by Region, 1995 – 2014	..............................................	13	
 
		
1	
CHAPTER 1 INTRODUCTION 
The relationship between a nation’s expenditure on health care and its gross national 
income has attracted much attention in the health economics literature.  Research interest in this 
relationship has been heightened by the observation that for many countries, aggregate health care 
expenditures have tended to grow over time at a rate faster than the rate of growth of gross domestic 
product.  This observation, when considered together with empirical evidence from mainly 
developed economies of the OECD, has led many researchers and policy makers to view health 
care as a luxury good; that is, that the elasticity of demand for health care exceeds unity.  When 
taken together with other evidence from empirical research that has found gross domestic product 
to be the most important determinant of health care expenditures, the view of health care as a 
luxury good poses the bleak implication that efforts at health care cost containment may be largely 
beyond the reach of policy. 
From a policy perspective, two main considerations underlie the keen interest that has 
evolved around understanding the determinants of health care expenditures.    A review of these 
two features will be instructive as to the rationale for this research and its contribution to the 
literature. 
1.1 Objectives and Challenges of Health Systems 
Many health care systems have the objective to provide universal access to health care, 
both in terms of the population covered and in terms of the range and quality of care provided.  
The Alma Ata Declaration of the International Conference on Primary Health Care (1978), 
provided the basis for this objective.  The declaration identified health care as a fundamental 
human right and set a goal of health for all by the year 2000.  It further identified Primary Health 
Care as the best approach for achieving universal access to essential health services, and urged 
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signatories, world governments and funding agencies to embrace the concept and to support its 
wide adoption in all countries, with immediate emphasis on developing countries. 
Many countries subsequently incorporated explicit goals for universal coverage in their 
national health policies.  Others that have not made such explicit commitments to universal 
coverage have nonetheless pursued objectives to encourage broad access, with explicit 
commitments to provide essential health care to vulnerable, impoverished and underprivileged 
groups.  The objective of universal health care delivery has involved a careful balancing of efforts 
at efficient, cost-effective health care provision with an imperative to protect individuals and 
families from catastrophic financial consequences due to episodes of illness. This is accomplished 
through health financing that allows for the pooling of health and financial risk across the 
population. In practice, health systems have employed a myriad of health financing schemes, 
ranging from tax-funded systems of national health insurance to systems of private health 
insurance with employer and/or individual mandates to provide or purchase health insurance in 
lieu of payments into a national pool, or various shades and combinations of these. 
Methods for health care provision have similarly varied across health care systems.  Many 
developing countries and countries that adopted tax funded national insurance schemes utilize 
systems of publically funded and operated hospitals, health facilities and health care personnel.  
Other systems allow for private but publically regulated provision.  In practice, most health 
systems employ some combination of public provision and private but regulated provision to foster 
competition with the aim to achieve efficiencies in cost and delivery. 
Efforts at providing quality health care have produced mixed results across countries and 
regions.   Prior to the adoption of health care reform in 2010 the United States implemented a 
system of private health insurance for the majority of its population.  Affordability was achieved 
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through employer-provided group insurance, which allowed for cost savings by pooling across 
large groups of employees.  Tax funded government insurance programs provided health care 
coverage for vulnerable groups.  Among these were Medicare, the government tax-funded health 
insurance program for the elderly, and Medicaid, which provided health insurance for poor 
individuals and families. The Children Health Insurance Program (CHIP), a federal-state 
partnership, provided health insurance for children, and in some cases pregnant women, from 
families with income too high to be eligible for Medicare. Despite the availability of these health 
insurance programs, 16.3 percent of Americans, about 49.9 million people, were without health 
insurance and therefore access to health care in 20101.  Prominent among the causes of lack of 
access to health care for many Americans was the relatively high cost of health care.  The US ranks 
first among comparable industrialized nations in measures of spending on health care.  In 2010 
health care spending accounted for 17.6 percent of U.S. GDP.  Total expenditures were $2.6 
trillion, amounting to $8,402 per person in 20102.   
While the U.S. consistently ranks first among health systems in expenditures on health 
care, rankings of health care system performance and health outcomes regularly place the U.S. 
unfavorably when compared to countries of similar economic status.  In a World Health 
Organization ranking of 191 health systems, the U.S. placed 37th for overall performance3. U.S. 
life expectancy at birth in 2013 was 78.8 years, 1.7 years less than the OECD average of 80.5.  On 
yet another measure of health outcomes, the U.S. infant mortality rate was 5 deaths per thousand 
live births, 1.2 deaths above the OECD average of 3.84.  Relatively high health care spending 
																																																						
1	U.S. Census Bureau, Current Population Reports, P60-245, Income, Poverty, and Health Insurance Coverage in 
the United States: 2012.	
2 Health Care Costs: A primer, Kaiser Family Foundation, May 2012 
3 The world health report 2000 — health systems: improving performance. Geneva: World Health Organization, 
2000 
4 Health at a glance 2015: OECD indicators 
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coupled with unsatisfactory measures of health outcomes has spurred a debate among health 
practitioners and policy makers about waste and inefficiencies in the U. S. health care delivery 
system. 
Compounding the problems with U.S. health care delivery outlined above are concerns 
about budgetary implications of projections regarding the solvency of the tax-funded health 
insurance programs that provide coverage for about 152 million Americans.  The Congressional 
Budget Office estimates that federal government spending on health care rose from 2 percent of 
GDP in 1985 to about 5.5 percent in 2016, and is projected to be as much as 8.9 percent of GDP 
by 2045.  Excess cost growth, defined as the growth rate of health care spending per person relative 
to the growth rate of GDP per person, adjusted for demographic changes, will average about one 
percentage point between 2016 and 2046.  With regards to the Hospital Insurance Trust Fund, 
which is funded by dedicated payroll taxes and which pays benefits under Medicare Part A, the 
CBO projects that expenditure from the trust fund will out strip receipt in 2020, and the fund will 
become exhausted by the year 20265.  
In the United Kingdom, health care is universal.  It is provided to all residents, in most 
cases, at no cost at the point of use.  The National Health Service (NHS), which oversees the 
provision of health care, is funded from general taxation.  It maintains a network of hospitals, 
doctors and other care providers and in limited cases procures care from independent and private 
providers.  Private health care and insurance exists alongside the NHS, and is utilized by about 10 
percent of the population, often for care or services in addition to what is covered by the NHS or 
to reduce wait times for referral services. 
																																																						
5 Congressional Budget Office: The Long term Budget outlook 2016  
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The British health care system is often held out in international comparisons as a model of 
quality and efficiency in health care delivery.  Patient and public engagement and feedback are 
explicit requirements of the functioning of the health care delivery system; and the NHS is 
internationally regarded for its innovation and leadership in the tools of monitoring and evaluation.  
Annual patient surveys of the quality of care provided by the NHS regularly puts ratings at very 
good or excellent in upwards of two thirds of patients surveyed6. 
Expenditures on health care, on a per capita basis and as a share of GDP are on the lower 
end in comparison to other countries of similar social and economic status.  Per capita health care 
spending in 2012 was $3,289, lower than the OECD average of $3,484.  This spending amounted 
to 9.3 percent of GDP, the average for the OECD7.  The United Kingdom therefore is able to 
provide a high quality and efficient health care at lower costs than average among developed 
countries. 
Like health systems in other developed countries, British health care is beset with concerns 
about its long term viability in view of rising costs and funding pressures.  A demographic shift 
towards an aging population will mean additional costs associated with an increase in the number 
of people with chronic illnesses. Lifestyle choices leading to an increase in alcohol use, smoking 
and obesity will be associated with rising prevalence of conditions like diabetes and cardiovascular 
disease.  The resulting rise in demand for health care are expected to lead to rising costs in excess 
of funding.  The NHS faces a funding deficit of 30 billion pounds by 2020.  The government has 
pledged increased budgetary funding of 8 billion pounds per year, leaving 22 billion pounds per 
year to be covered through productivity and efficient gains. 
																																																						
6 www.health.org.uk/publications/research_reports/patient_and_public.html 
7 OECD Health Statistics 2014 
		
6	
The problems that characterize health care in the cases discussed above are challenging, 
but these pale in comparison to the situation in Africa.  The continent lags the rest of the world by 
significant measures in nearly all international comparisons of the common benchmarks of health 
status and outcomes.  The state of health care infrastructure, health workforce, and financing can 
only be described as rudimentary, at best. 
By some account, the poor state of health in Africa and the enormous challenges faced by 
countries in delivering adequate health care can, in part, be attributed to Africa’s geography.  
Africa is predominantly tropical, and its tropical climate is particularly suitable for the ecology of 
infectious diseases. Sachs and Bloom (1998) provide the following illustration of the link between 
tropical climate and disease ecology for the case of malaria, traditionally one of the biggest causes 
of morbidity and death in Africa.  The mosquito species anopheles gambiae is the most important 
vector of falciparum, which in turn is the most virulent form of plasmodium, the parasite that 
causes malaria.  Anopheles gambiae is indigenous to and more prevalent in sub-Saharan Africa 
than in other tropical areas.   Additionally, the latency period of plasmodium inside its vector is 
temperature dependent8, being much shorter the higher the ambient temperature.  Thus in tropical 
areas, the latency period of plasmodium is much shorter relative to the life span of the mosquitoes 
that are vectors of the parasite.  The mosquitoes are therefore much more likely to become infective 
before they die in tropical climates than they are in temperate ones. 
Data from the World Health Organization (WHO) indicate that average life expectancy at 
birth in Africa in 2015 was lowest at 60.0 years, below the global average of 71.4 years.  The 
under-five mortality rate was the highest among the WHO regions at 81 per 1000 live births, as 
compared to the world average of 43. Infectious and communicable diseases that have largely been 
																																																						
8The latency period is time it takes for a mosquito to become infective after it absorbs plasmodium from an 
individual infected with malaria.  
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contained in other regions of the world continue to be major causes of death in Africa.  In 2012, 
the leading causes of death were HIV/AIDS related deaths, which accounted for 11.5 percent of 
all deaths in Africa, and 70 percent of all HIV/AIDS related deaths worldwide; lower respiratory 
tract infections, including pneumonia, influenza and bronchitis, 11.5 percent; diarrheal diseases, 
6.7 percent; malaria, 5.9 percent and stroke, 4.4 percent (Africa Check, 2014). 
As dire a picture of the health status of much of Africa as the above exposition depicts, the 
state of the health infrastructure that must respond to these challenges is equally disconcerting.  As 
the WHO reports, Africa, with more than 24% of the global burden of disease, has access to just 
3% of health workers and less than 1% of the world’s financial resources.  Hospital bed density in 
2009 was lowest in Africa, at 10 per population of 10,000, as compared to 63 per 10,000 in Europe.  
There were just 2 physicians per population of 10,000 in Africa, compared to 13 per 10,000 
worldwide and 32 per 10,000 in Europe (World Health Statistics, 2009).  These numbers clearly 
fall short of requirements to address health needs in Africa.  Kinfu et. Al (2008) examine whether 
current preservice training can improve the shortage of health workers, taking into account 
population increases and attrition to the health workforce from various sources.  They conclude 
that current preservice training are insufficient to maintain numbers even at their current levels. 
Improvements in Arica’s health outcomes and the state of its health infrastructure will 
require significant additional investment, but current trends are not encouraging.  Health care 
spending, both per capita and as a share of GDP, tends to be much lower in Africa as compared to 
other regions, and fall short of what is required to meet the challenges of health care delivery.  
Average per capita total healthcare spending in the region in 2014 was $306, compared with an 
OECD average of $3,734, and $9,403 for the US.  This however masks the large disparity in 
spending across countries.  The Central African Republic spent $25 per person on health care, the 
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lowest in the region, while Equatorial Guinea recorded the highest spending per capita, $1,163.  
Average share of GDP spent on health care was 6 percent, compared to 9.28 percent for the OECD 
and 17.14 percent for the US. 
The share of total government spending that goes to health care is sometimes cited as a 
measure of the extent to which the government prioritizes health care.  In 2014, the average share 
was 10.05 percent, also masking a large variation among countries.  The Eritrean government spent 
just 3.6 percent of its budget on health care, while at the higher end, the figure for Malawi was 
16.77 percent.  Just four of the fifty-two countries, Ethiopia, Malawi, Gambia and Swaziland, had 
health share of government budget at or above 15 percent, as stipulated by the Abuja declaration 
of 20019.  As a final note of the greater health risks that Africans in general face, out of pocket 
spending remains a high proportion of health care spending.  It amounted to 33.30 percent of total 
health care spending in 2014, compared to the OECD average of 19.16 percent and 11.05 percent 
for the US.  Thus, Africans, with their meager financial means, bear a disproportionate share out 
of pocket spending for health care, which further impedes access to health care and exposes them 
to greater risks of financial catastrophe from episodes of illness. 
The review presented above reveal a salient point, that health systems around the world 
have a monumental responsibility for delivering health care to their people, and face serious 
challenges in this endeavor.  Whether it be about extending access and improving outcomes for 
the value of spending in the US, solvency and quality concerns in the UK, or infrastructure and 
public health issues in Africa, various reforms, restructuring and other responses will be required 
if health systems are to be adequately positioned to deliver quality care for the long term.  A careful 
mix of significant additional funding, efficiency gains and cost savings will be essential 
																																																						
9 Heads of States of the African Union (AU) met in Abuja, Nigeria in April 2001 and pledged to allocate at least 15 
percent of each country’s budget to the improvement of health care. 
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requirements to these efforts, and this leads to the second major concern that has spurred interest 
in the relationship between healthcare spending and GDP, namely, health care cost.  Health care 
is expensive, and costs tend to rise over time.  This tendency has significant implications for efforts 
at health care reform. 
1.2 The Rising Cost of Healthcare 
Figure 1.1 shows total health care spending per capita for the United States, the OECD 
countries and Africa for the period 1995 to 2014.  In all three regions, health care spending per 
capita rose over the referenced period.  Average growth rates were 4.90 percent for the United 
States, 5.21 percent for the OECD region, and 4.94 percent for Africa.   These increases occurred 
amid the challenges to health care the three regions experienced as discussed earlier in this chapter.  
A more vivid indication of the burden of rising spending on health systems can be seen in Figure 
1.2, which shows health care spending as a share of gross domestic product.  The three regions 
have all seen rising shares of health care expenditures in GDP, an indication that health care 
spending has been rising at a rate faster than the growth of GDP.  For the United States, the share 
of health care spending in GDP rose from 13.89 percent in 1995 to 17.41 percent in 2014, while 
for the OECD region the average share rose from 7.29 percent to 9.28 percent in the same period.  
For Africa, the average share of health care spending in GDP rose from 4.78 percent to 6.08 percent 
between 1995 and 2014.  As has been pointed out in the literature, growth rates of health care 
spending in excess of GDP are unsustainable in the long term, as a nation cannot indefinitely 
commit ever larger shares of its resources to health care without a sacrifice of other services that 
may also be important for the wellbeing of its people10.  But as can be seen in Figure 1.3 below, 
rising shares of health care in GDP has been the norm.  The figure shows the growth rates of the  
																																																						
10 See, for example, Kotlikoff and Hagist (2005) 
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share of health care spending in GDP for the three regions, a measure of the excess growth of 
health care spending over GDP growth.  With few exceptions this variable has been positive during 
the period, particularly for the United States and the OECD region, indicating increasing shares of 
healthcare in GDP. 
 A number of explanations have been put forth for the tendency of health care spending to 
rise over time.  The most prominent explanation identifies the rising use of advanced medical 
technology and new medicines as a leading cause.  Other studies point to the use of fee-for-service 
methods of medical service reimbursement as an important source of health care cost growth, given  
Figure 1.1 
Total Health Care Spending, 1995 – 2014, by region	
 
 
Source: WHO Global Health Expenditure Database.  Figures in thousand constant (2010) purchasing power 
parity (PPP). 
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its inherent lack of incentives for physicians to control costs.    Still other studies point to the 
increased use of insurance and other health care financing mechanisms that significantly reduce 
the cost to the user at the point of service, providing an incentive for overuse.  All of the 
aforementioned explanations for rising health care costs lead to higher utilization per person, 
irrespective of demographic group.  In many countries, on the other hand, there is a tendency for 
a demographic shift toward an aging population over time.  As older people use more medical 
care, this demographic shift has also been identified as a source of growing health care spending. 
An explanation for rising health care costs that draws on consumer preference theory posits 
that health care is a technical luxury, with an income elasticity greater than 1.  In this view, rising 
health care spending in excess of GDP growth is inevitable as countries undergo economic growth.  
Figure 1.2 
Total Healthcare Spending as a Share of GDP, 1995 – 2014, by region	
 
 
Source: WHO Global Health Expenditure Database.  Expressed as percent of GDP. 
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Studies that have examined the determinants of health care spending have consistently found a 
significant and often predominant role for income, after controlling for the other factors including 
those discussed above.  Less conclusive has been the size of the income effect.  While most studies 
have found elasticities at or above 1, a few have found elasticities below 1. 
Finally, what is true for overall health care spending appears to be true of government 
spending on health care.  Figure 1.4 shows general government health expenditures as a share of 
general government expenditures, 1995 to 2014.  The share has risen for all three series over the 
referenced period.  The growth rate of government health care spending as a share of total 
government expenditures increases sharply toward the end of the period for the United States and 
the OECD average, highlighting the budgetary and solvency issues with projections for 
Figure 1.3 
Growth of Health Care Spending as a Share of GDP, 1995 – 2014, by region		
 
 
Source: WHO Global Health Expenditure Database.  Expressed as percent of GDP. 
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government sponsored health care programs discussed earlier.  With Africa, on the other hand, 
there is a slowdown in the growth of government health care spending share, and even a decline 
in government spending on health care.  This apparent deprioritizing of health care is the opposite 
of what is prescribed given Africa’s health care challenges and as mandated by the aforementioned 
Abuja declaration. 
The picture presented in this review of health care systems and spending is one of a need 
for expansion of services, increased population coverage and plugging of budgetary and other 
funding holes for the long term viability of health care delivery systems across countries; all at the 
same time as health care spending rises and takes up increasing shares of available resources.  
Figure 1.4 
General Government Health Expenditures as a Share of General 
Government Expenditures, 1995 – 2014, by region	
 
 
Source: WHO Global Health Expenditure Database.  Expressed as percent of GDP. 
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Orszag and Ellis (2007) observe that the evidence does not show that higher health care spending 
produces better health outcomes.  Cost containment and efficiency gains will clearly have to be 
part of any efforts at reforming or reorganizing health care systems to deliver more and better 
services to more people. 
The research that has evolved around the question of what determines the level and 
behavior of health care spending is an attempt at making a contribution to cost containment and 
reform of health care delivery.  As already mentioned, a persistent theme in the literature that this 
line of research has produced is that gross domestic product is a significant, and in some studies  
the biggest, determinant of health care spending, at least at the aggregate level.  Furthermore, there 
is a debate as to the size of the income elasticity of health care expenditures, with many studies 
finding an elasticity greater than 1.  As these studies mostly cover wealthy countries, and in 
particular countries of the OECD, it is of interest to inquire if similar findings would be arrived at 
from a study of a sample of countries of a different socio-economic background and level of 
development than OECD countries. 
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CHAPTER 2 LITERATURE REVIEW 
The lack of theoretical basis for the determinants of health care expenditures has given rise 
to an active area of research attempting to provide empirical evidence as to the nature of the 
relationship of health care expenditures to its determinants.  Much of this effort has been 
concentrated at explaining these relationships for countries of the Organization for Economic 
Cooperation and Development (OECD), largely because these are the countries for which reliable 
data have historically been available.  The results to date are mixed, but a consensus appears to be 
building around a number of key findings.  First, it appears from the evidence that the major 
determinant of per capita health care expenditures is GDP per capita.  Newhouse (1977), using 
data on a cross section of 13 OECD countries, found that 92 percent of the variation in per capita 
health care expenditures could be explained in terms of variation in per capita GDP.  Subsequent 
research has largely provided support for this finding. 
With GDP per capita having been found to play the major role in determining per capita 
health care expenditures, a strand of research has focused on empirically estimating the parameters 
of the relationship.  The evidence here again is mixed, but the prevailing view emanating from this 
research is that the income elasticity of health care expenditure exceeds unity, implying that health 
care is a luxury (Kleiman (1974), Newhouse (1977), Gerdtham, Sogaard et al. (1992)).  The 
evidence is however not conclusive, with other studies finding an elasticity of unity Hitiris and 
Posnett (1992), and still others finding a coefficient of less than unity (Parkin, McGuire et al. 
(1987)).  These estimates are based on cross-sectional analyses of a small number of countries, 
which have been criticized for the resulting small size of the data set (Parkin, McGuire et al. (1987), 
Hitiris and Posnett (1992)).  Efforts to address the issue of small sample size have involved the use 
pooled and time series data to increase the sample size.  Hitiris and Posnett (1992) use pooled time 
		
16	
series observations on 20 OECD countries to obtain a sample size of 560.  Their results confirm a 
strong positive relationship between per capita health care spending and per capita GDP, with an 
income elasticity of around unity.   
The use of pooled and time series data has shifted the focus of research to determining the 
sensitivity of results to assumptions about the time series properties of the data.  Hansen and King 
(1996) find that both per capita health expenditures and GDP have unit roots and are not 
cointegrated.  They therefore suggest that previous studies of pooled and panel data that found 
strong relationships between these variables might show a spurious relationship.  Blomqvist and 
Carter (1997) also find evidence of unit roots in per capita health care expenditures and GDP, but 
in contrast to Hansen and King (1996), they find evidence of a cointegrating relationship, with a 
long run elasticity of around unity.  Gerdtham and Lothgren (2000) provide evidence that generally 
support these findings.  In contrast, McCoskey and Selden (1998) use panel unit root tests to reject 
the presence of a unit root in either per capita health care expenditures or per capita GDP.  Their 
results are however sensitive to the inclusion of a time trend in their estimation equation.  
  Estimates of the relationship between per capita health care expenditures and per capita 
GDP and the size of the income elasticity have also been found to be sensitive to both the model 
specification and the estimation methods used.  However not as much research has been directed 
at assessing the sensitivity of the results to the sample of countries, largely due to the unavailability 
of reliable data.  In particular, there is sparse evidence of the nature of the relationship between 
health care expenditures and GDP for African countries.   An early effort at bridging this gap in 
the literature is provided by Gbesemete and Gerdtham (1992).  Their cross-sectional study of a 
sample of 30 African countries for 1984 found that GNP per capita has the largest impact on per 
capita health care expenditures, with an elasticity at around unity.  Murthy and Okunade (2009) 
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reach similar conclusions in their cross-sectional study of 44 African countries using 2001 data, in 
addition to finding a significant role for foreign aid in determining health care expenditures.  In 
contrast to these cross-sectional studies, Jaunky and Khadaroo (2008) use time series techniques 
on a panel of 28 African over 1991 – 2000.  They conclude that health care expenditures per capita 
and GDP per capita are nonstationary and cointegrated, with an elasticity greater than unity for 
public health care expenditures and about unity for private health care expenditures. 
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CHAPTER 3 A MODEL OF HEALTH CARE DETERMINATION 
As has been noted in previous studies, there is no firm theoretical basis as to the 
determinants of a country’s total health expenditures.  It seems reasonable, however, that 
expenditures would be constrained by the total amount of resources the country has available for 
spending on all needs.  The most comprehensive measure of resources a country has for meeting 
current needs is its gross domestic product (GDP). We would therefore expect GDP per capita to 
be a determinant of total healthcare expenditures.   Additionally, we would expect factors that 
influence the demand and supply of health care to be influential in the determination of healthcare 
expenditures.  On the demand side, demographics and disease ecology would be important, while 
on the supply side, we would expect the characteristics and institutional arrangements for health 
care delivery and financing to influence a country’s total health care expenditures. 
Previous studies have found GDP per capita to exert the greatest influence on per capita 
health care spending. Newhouse (1977) found in a bivariate regression that more than 90 percent 
of the variation in per capita medical expenditure could be explained by variation in per capita 
GDP in a sample of 13 OECD countries. Hitiris and Posnett (1992) confirmed this finding using 
pooled time series and cross sectional data from an expanded list of 19 countries.  They found that 
per capita GDP explained upwards of 91 percent of the variation in per capita health care spending. 
Leu (1986) argues that increased public provision and financing of health care services 
should be associated with higher health care expenditure.  Increased public provision, he argues, 
lessens competition and reduce incentives for cost minimization.  Additionally, bureaucrats in 
public institutions act as budget maximizers, increasing provision to maximize their own welfare. 
Finally, public financing lowers the cost to users of health care services and may lead to overuse.  
Culyer (1989) emphasizes methods of reimbursement for medical services as relevant for cost 
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containment.  He proposes that retrospective reimbursement, such as fee for service methods of 
payment are likely to see higher overall expenditure per head, whereas systems that use prospective 
reimbursement would tend to lower tendencies for cost inflation. 
Demographic and health status variables that affect the demand for health care have also 
featured prominently in the existing literature.  Gertham et al. (1992) include the proportion of the 
population age 65 and above and the degree of urbanization of the population as measures of health 
care utilization, and the female labor force participation ratio as a measure of the substitution of 
informal for formal care.  They however find these variables to be statistically insignificant in their 
most preferred model.  Gbetemese and Gerdtham (1992) found the percentage of births attended 
by medical staff to be statistically significant for the determination of health care expenditures.  
Three other demographic and health status measures included were however found to be 
insignificant, namely, the crude birth rate, the degree of urbanization and the percentage of 
population under 15 years of age. 
Previous studies have also addressed the issue of the appropriate functional form for the 
estimating equation.  Most studies employ the double-log functional form in which both total 
health expenditures per capita and gross domestic product per capita are entered as natural logs.  
This practice is not only convenient for its tractability in this line of research, but it allows for the 
interpretation of the coefficient estimates as elasticities.  Using OECD data, Parkin et al. (1987) 
demonstrate that results can be sensitive to the functional form of the estimating equation, noting 
that different functional forms can support competing theories using the same data.  They therefore 
urge caution in empirical examination of health care spending as it relates to functional form.  
Gertham et al. (1992) address the issue of functional form within the framework of the Box-Cox 
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transformation. Their results provide evidence in favor of the double-log functional form against 
three alternatives, namely, the linear, exponential and semi-log functional forms. 
Guided by results from previous research, I assume that health care expenditures per capita 
is determined by a country’s GDP per capita, as well as other variables that describe or proxy for 
characteristics of the health care delivery system and demographic characteristics of the country, 
and the relationship is expressed using the double-log functional form: 𝐻𝐶𝐸$% = 𝛽( + 𝛽*𝐺𝐷𝑃$% + 𝛾/𝑋$% + 𝜀$%       (3.1) 
In this equation, HCEit is the log of health expenditure per capita, GDPit is the log of gross 
domestic product per capita and Xit is a vector collecting all other factors that may affect health 
care expenditures per capita.  The novelty in this study is to observe that, for the population under 
study, health care expenditures may be an important determinant of GDP per capita.  This 
observation, taken together with equation (1), would suggest that health care expenditure and gross 
domestic product are jointly determined in the data.  If this holds true, failure to account for the 
endogeneity of GDP per capita would result into simultaneity bias in estimates of the parameters 
of equation (3.1). 
The neoclassical growth model, extended to human capital, postulates a production 
function of the form 𝑌$% = 𝐾$%4𝐻$%5 𝐸$%𝐿$% *7475 
where Yit is GDP, Kit is the capital stock, Hit is the stock of human capital, Eit is an efficiency 
parameter that determines the productivity of labor and Lit is the labor force.  The term EL is 
interpreted as efficient units of labor.   The growth empirics literature often proxies the stock 
human capital by measures of education attainment and health status of the work force.  To make 
the measure of human capital relevant to this study I use the stock of health capital in the country 
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as the measure of human capital.  The production function above thus relates gross domestic 
product to the stock of health capital in the country.  For the purpose of the analysis in this paper, 
however, it would be more convenient to express the production function as relating gross 
domestic product to total health care expenditures. I therefore assume that the stock of health 
capital in a country accumulates with the level of health care expenditures, and specify an 
accumulation process of the form: 𝐻$% = 𝐻$%7*(𝐻𝐸$%): 
where HEit is current health care expenditures and 𝜂 is a parameter measuring the efficiency with 
which health care spending is transformed into health capital stock.  I use the multiplicative form 
to exploit the log transformation of the variables I use in the model.  Taking logs of the production 
function and the health accumulation equation, and using the accumulation equation to substitute 
the log of health care expenditures for the log of health capital stock in the production function, I 
derive, after some algebra, an equation of the form 𝑙𝑛 >? $% = 𝛼( + 𝛼*𝑙𝑛 AB? $% + 𝛼C𝑙𝑛 D? $% + 𝛼E𝑙𝑛𝐿$% + 𝛼F𝑙𝑛𝐻$%7* + 𝑢$%   (3.2) 
The variables 𝑙𝑛 AB? $%and 𝑙𝑛 >? $% in equation (3.2) are the same as 𝐻𝐶𝐸$% and 𝐺𝐷𝑃$% respectively 
in equation (3.1).  I therefore use common notation in the health care expenditure equation (3.1) 
and the production function (3.2) to express a two-equation system of the form: 𝐻𝐶𝐸$% = 𝛽( + 𝛽*𝐺𝐷𝑃$% + 𝛾/𝑋$% + 𝜀$% 𝐺𝐷𝑃$% = 𝛼( + 𝛼*𝐻𝐶𝐸$% + 𝛼C𝑙𝑛 D? $% + 𝛼E𝑙𝑛𝐿$% + 𝛼F𝑙𝑛𝐻$%7* + 𝑢$%   (3.3) 
If measures of the per capita stock of physical capital and the population are available and are 
believed to be uncorrelated with the error term in equation (1), 𝛽* can be consistently estimated by 
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using these variables as valid instruments for per capita GDP in the health care expenditure 
equation (3.1). 
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CHAPTER 4 DATA 
Data on total health care spending, gross domestic product and national populations are 
from the global health expenditure database of the World Health Organization. The WHO updates 
the database annually, with data obtained from publicly available reports from national 
governments, private sector sources and international organizations. Data on national capital 
stocks are available from the Penn World Tables, version 8.1. Both the Global health expenditure 
database and the Penn World Tables present data in a manner as to make them internationally 
comparable.  However, the WHO cautions that country data may still differ in terms of definitions, 
data collection methods, population coverage and estimation methods used. Total health care 
expenditures and gross domestic product are measured in constant 2005 purchasing power parities.  
National capital stocks are measured at current purchasing power parities.  The data consists of 
annual observations on 42 African countries for 1995 to 2011. 
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CHAPTER 5 METHODS AND ESTIMATION 
 5.1 Tests of Stationarity 
The time series nature of the data raises the question of whether the data are stationary.  As 
is well known, ordinary least squares estimates from nonstationary data result into spurious 
regressions, in which a significant effect is found even if the variables are independent.  Taking 
first differences of variables that are I(1) results into stationary data on which regression 
procedures can produce consistent estimates of population parameters. 
I use two tests of unit roots to test for nonstationarity of the log of total health care 
expenditures per capita and the log of GDP per capita. The first is the Augmented Dickey-Fuller 
(ADF) test, which is based on the regression  
Δyit =α i +δ it + βi yt−1 + ρijΔyi,t− j + ε it
j=1
pi
∑  
where yit is observed over T time periods across N countries. The null hypothesis isH0 :βi = 0
against the alternative that the data is trend stationary,H1 :βi <1 .  The t-statistic for this test 
follows a nonstandard distribution that has been tabulated in Fuller (1976).  As McCoskey and 
Selden (1998) point out, when the time dimension is relatively short, adding lags to the ADF 
regression results into a loss of observations as the number of parameters to be estimated increases.  
The resulting loss of degrees of freedom can cause the ADF test to have low power.  
To increase the power of the test, I follow the lead of other studies that utilize a panel unit 
root test to exploit the panel nature of the data.  The power of the IPS test (Imp, Paesaran et. Al., 
2003) increases as the cross sectional dimension gets larger.  The IPS test is based on the average 
of t-statistics from the country-by-country ADF tests: 
tNT =
1
N tiT (pi )i=1
N
∑  
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where tiT is the ADF t-statistic for country i when pi lags are used in the country specific ADF 
regression.  The null hypothesisH0 :βi = 0 for all i is tested against the alternativeH1 :βi < 0 for a 
subset of the N countries.  Failure to reject the null is evidence that the panel series is I(1) around 
a linear trend. 
5.2 Test for Cointegration 
One method of determining the existence of a long run relationship between per capita total 
healthcare expenditures and GDP per capita is to test for the existence of a cointegrating 
relationship.  If the two variables are integrated of order 1, as evidenced by findings in this paper, 
then a cointegrating relationship exists if a stationary linear combination of the two variables can 
be found.  Formally, let HCEt be the log of total health expenditures per capita and GDPt be the 
log of GDP per capita.  Then, under the assumption that HCEt and GDPt are both I(1), a 
cointegrating regression can be expressed as: 
HCEt = b0 + b1t + b2GDPt + ut                                        (5.1) 
Equation (5.1) would be a valid cointegrating relationship if ut = HCEt - b0 - b1t - b2GDPt is a 
stationary variable.  A test for stationarity of ut is therefore a test of whether HCEt and GDPt are 
cointegrated. 
To test for cointegration between total healthcare expenditures per capita and GDP per 
capita I apply the residual-based test for cointegration proposed by Engle and Granger (1987).  The 
test is based on applying the Dickey-Fuller t-test for stationarity to the residuals ût from the OLS 
estimates of equation (1): 
∆ût = 𝛿ût-1 + et 
If the errors in the Dickey-Fuller equation, et, are believed to be serially correlated, then a sufficient 
number of lags of the regressand ∆ût should be added to the equation to make the errors serially 
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uncorrelated.  The test in this case is the Augmented Dickey- Fuller test.  Under the null hypothesis, 
H0: 𝛿 = 0, the errors ût are nonstationary, and therefore HCEt and GDPt do not cointegrate.  The 
test is therefore a test of no cointegration.  Failure to reject the null is evidence of the lack of a 
long run relationship between total healthcare expenditures per capita and GDP per capita. 
A caveat to using tests of cointegration to determine long run relationships between total 
healthcare expenditures per capita and GDP per capita is that the brevity of the time dimension of 
the data in this study makes inferences from results of such tests unreliable.  As is well known, the 
power of tests of stationarity declines the smaller the number of observations in the data.  With 
just 17 observations per panel, the test outlined above is likely to have low power.  This would 
result in a tendency for the test to fail to reject the null hypothesis if it is indeed false.  Thus, the 
potential low power of the Dickey-Fuller test in this exercise is likely to lead to findings of no long 
run relationship.  This is likely to be an artifact of the data, however, as it seems intuitive that there 
must be a long run relationship between healthcare expenditures per capita and GDP per capita.  
Numerous studies outlined in the literature review section of this paper have found strong evidence 
of such relationship.  A finding of no cointegration would therefore not preclude the use of other 
methods to establish the relationship, if any, between total healthcare expenditures per capita and 
GDP per capita.  Regardless of the results, the cointegration exercise is interesting in that it sheds 
light from an alternative data set on an issue of much debate in the existing literature. 
 5.3 Model Estimation 
The data contain seventeen-time series observations on each country in the sample.  The 
small sample size would render unreliable any coefficient estimates from country-specific time 
series regressions that rely on methods that are only asymptotically valid.  To improve the 
reliability of the coefficient estimates, I utilize an estimation procedure that exploits the panel 
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nature of the data.  The generalized method of moment (GMM) estimator allows for the estimation 
of coefficients on endogenous variables11. The procedure can be applied to panel data to estimate 
the average effect of an endogenous variable on a dependent variable in a sample of countries over 
a period of time.  For the multiple equation version of the GMM estimator, consider the equation  𝑦$J = 𝒛$J/ 𝜹$J + 𝜀$J			(𝑚 = 1, 2, … ,𝑀; 𝑖 = 1, 2, …𝑛) 
The equation specifies a system of M equations on observation i, where n is the sample size.  𝑦$J 
is the dependent variable for observation i in equation m.  𝒛$J is an Lm dimensional vector of 
possibly endogenous regressors, and 𝜹$J is an Lm dimensional vector of coefficients to be 
estimated.  𝜀$J is the error term in the equation m.  Imposing common coefficients across all M 
equations (𝛿$J=	𝜹), the system of equations becomes 𝑦$J = 𝒛$J/ 𝜹 + 𝜀$J 
Common coefficients imply that each equation m has the same number of regressors, so 𝐿J = 𝐿.  
Let 𝒙$J be a Km dimensional vector of instruments for equation m.  Then the GMM estimator is 
based on the sample analogue of the population orthogonality conditions  𝐸 𝒙$J𝜀$J = 𝐸 𝒙$J(𝑦$J − 𝒛$J/ 𝜹) = 0 
The expression above specifies a system of Km linear restrictions of the form 𝐸 𝒙$J𝑦$J − 𝐸 𝒙$J𝒛$!J/ 𝜹 = 0 
These Km linear restrictions must hold for each equation m.  Therefore the system of m equations 
has 𝐾JJ  orthogonality conditions.  To collect these orthogonality conditions in a single system, 
define 𝜎Z[ to be the 𝐾JJ -dimensional vector collecting moment conditions 𝐸 𝒙$J𝑦$J  from all 
																																																						
11 See Hayashi (2000) 
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M equations.  Let ΣZ] be a stacked 𝐾JJ ×𝐿 matrix collecting the matrices 𝐸 𝒙$J𝒛$J/  from all 
M equations. The 𝐾JJ  orthogonality conditions can therefore be written as  𝜎Z[ − ΣZ]𝜹 = 0 
To derive the sample analogue to these orthogonality conditions, let 𝑠Z[ = *` 𝒙$J𝑦$J*`  and 𝑆Z] =
*` 𝒙$J𝒛$J/*`  be the sample analogues of 𝜎Z[ and ΣZ] respectively.  Then the sample analogue of 
the orthogonality conditions is 𝑠Z[ − SZ]𝜹 = 0. 
Notice the dimension of the matrix SZ] is 𝐾JJ ×𝐿, and in general, 𝐾JJ ≠ 𝐿. As such, matrix SZ] is in general not a square matrix and not invertible.  As a result, there is no 𝜹 that solves 𝑠Z[ −SZ]𝜹 = 0.  If this difference cannot be set exactly to zero, it must be possible to find a 𝜹 that sets 
the difference as close as possible to zero.  The GMM estimate 𝜹 of the population parameter 𝜹 is 
the 𝜹 that minimizes the difference 𝑠Z[ − SZ]𝜹 in the following sense:  Let W, called a weight 
matrix, be a positive definite matrix of dimension 𝐾JJ × 𝐾JJ .  The GMM estimate 
minimizes the quadratic form 𝑄 = 𝑠Z[ − SZ]𝜹 7*𝑊 𝑠Z[ − SZ]𝜹  
 If W is chosen such that W= 𝑆7*, where S is a block matrix whose Smh block is *` 𝜀$J𝜀$f𝑥$J*` 𝑥$f/ , for m=1,2,…M and h=1,2,…,M, then we obtain the efficient GMM estimator. 
In the implementation of these methods, I estimate 17 equations (M=17), one equation for 
each year 1995 – 2011.  When the variables are in logs, the equations are of the form 𝐿𝑇𝐻𝐸$% = 𝛽( + 𝛽*𝐿𝐺𝐷𝑃$% + 𝜀$%,						𝑖 = 1,2, … 42; 𝑡 = 1995, 1996,… ,2011) 
LTHEit is the log of per capita total health care expenditures, and LGDPit is the log of per capita 
gross domestic product.  𝜀$% is an error term.  I allow for heteroskedasticity and serial correlation 
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in the errors, and therefore report standard errors that are robust to both.  For each country and 
year, I use the log of the capital to labor ratio (LCKit) and the log of the population (LPOPit) as 
instruments for LGDPit. LPOPit is a proxy for labor input.  Finally, I impose the cross equation 
restriction that 𝛽(, 𝛽* /are the same in each equation.  This is because I am interested in the 
average effect of LGDPit on LTHEit over the sample period for the sample of countries.   
If either LTHEit or LGDPit, or both are I(1), the above would represent a spurious 
regression.  I therefore first difference the data and run the following specification: 𝑑. 𝐿𝑇𝐻𝐸$% = 𝛽*𝑑. 𝐿𝐺𝐷𝑃$% + 𝜀$%,						𝑖 = 1,2, … 42; 𝑡 = 1996, 1997,… ,2011) 
differencing the data causes a loss of one observation, so the system now consists of 16 equations.  
In this specification, I use the growth rates of LCKit and LPOPit as instruments. 
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CHAPTER 6 RESULTS 
 6.1 Summary Statistics 
 Table 6.1 presents country means of the dependent and explanatory variables, where the 
averages are taken for the period 1995 to 2011.  Average GDP per capita ranges from $528.76 in 
the Democratic Republic of Congo to $20,355.08 in Equatorial Guinea.  While a few countries 
have GDP per capita that place them among the wealthy countries of the world, in reality the level 
of income inequality is so high that wealth is concentrated among a small minority elite, and the 
majority of the population have living standards and access to essential services that are no better 
than those in poorer countries. 
 Average spending on healthcare ranges from as little as $18.33 in the Democratic Republic 
of Congo to $642.29 in the Seychelles.  Average share of government spending in total health care 
spending generally tends to hover somewhat below the 50 percent mark.  Out of pocket spending 
tends to make up a higher share of the remaining spending than is found in wealthy countries.  The 
figures for average percentage of the population over sixty-five reflects two facts; life expectancy 
is less than sixty-five, and the demographic shift towards older population that is often observed 
in developed countries has not materialized in Africa. 
6.2 Unit Root Results 
Table 6.2 contains results from country-by-country ADF unit root tests as well as the result of the 
IPS panel unit root test on the panel of 42 countries.  As indicated in the table, only in four cases 
can the null of a unit root be rejected for the log of real GDP per capita (lGDPpc).  For the log of 
total health care expenditures per capita (lTHEpc_PPP), the null of a unit root was rejected in just 
7 cases.  These results provide evidence of unit roots in both the GDP and healthcare expenditure 
series, as other studies have found.  
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Table 6.1 
Summary Statistics: Means of Variables by Country, 1995 – 2011 
 
COUNTRY THEpc_PPP GDPpc GGHE_THE tb urb O65_ 
Angola 169.72 4,141.93 54.09 266.18 34.74 2.41 
Benin 60.95 1,385.33 48.26 80.29 39.38 2.91 
Botswana 499.61 10,297.99 64.50 764.65 53.82 3.10 
Burkina Faso 62.25 1,059.36 48.06 67.65 20.27 2.69 
Burundi 44.75 609.13 37.17 235.12 8.97 2.77 
Cameroon 97.12 2,091.91 23.63 283.35 47.34 3.35 
Cape Verde 181.80 3,880.15 76.13 156.18 55.89 5.31 
CAR 26.37 673.13 46.87 836.82 37.97 3.94 
Chad 57.74 1,256.93 36.33 147.71 21.74 2.78 
Comoros 57.65 1,399.31 49.51 37.76 28.01 2.93 
Congo 109.68 4,356.94 58.24 365.71 60.06 3.65 
Cote d'Ivoire 150.07 2,509.47 26.54 302.12 45.74 2.89 
DRC 18.33 528.76 20.79 326.94 36.57 2.90 
Djibouti 131.03 2,023.14 65.38 619.82 76.67 3.25 
Egypt 363.19 7,531.81 40.74 23.53 42.90 5.01 
Equatorial Guinea 588.61 20,355.08 70.61 108.00 38.92 3.50 
Ethiopia 28.55 659.81 51.76 362.82 15.45 3.15 
Gabon 508.97 15,821.78 41.11 496.35 81.66 5.71 
Gambia 61.01 1,364.48 46.66 179.53 50.43 2.62 
Ghana 112.83 2,964.79 59.91 129.65 45.89 3.25 
Guinea 34.73 1,036.32 29.64 216.82 32.18 3.32 
Guinea-Bissau 73.06 1,274.14 23.06 332.00 39.24 3.30 
Kenya 72.15 1,703.33 42.15 292.94 21.01 2.74 
Lesotho 128.03 1,603.58 58.02 1,026.88 21.15 4.47 
Madagascar 56.80 1,261.45 48.67 278.00 28.51 2.94 
Malawi 39.50 665.61 54.82 377.47 14.77 3.04 
Mali 83.32 1,309.78 42.72 72.06 30.74 3.11 
Mauritania 86.89 2,112.07 46.54 215.00 51.49 3.16 
Mauritius 469.37 11,098.00 50.26 23.59 41.97 6.46 
Morocco 225.58 4,680.31 31.10 113.47 54.61 5.50 
Namibia 420.71 6,056.15 60.44 1,207.65 35.34 3.36 
Niger 44.85 712.55 31.31 170.59 16.59 2.48 
Nigeria 179.03 4,982.83 28.82 327.47 37.69 2.79 
Rwanda 64.44 846.61 48.60 95.00 17.59 2.76 
Sao Tome 247.55 2,181.12 37.83 108.71 55.99 4.40 
Senegal 82.23 1,776.48 43.56 146.76 40.89 3.15 
Seychelles 642.29 16,366.43 88.39 21.10 50.80 7.29 
Swaziland 337.77 5,413.70 62.10 940.18 22.29 3.09 
Tanzania 49.95 1,051.51 47.07 214.00 24.10 2.94 
Togo 64.85 1,152.80 33.24 71.18 34.30 2.82 
Tunisia 416.39 7,268.00 53.73 26.06 64.20 6.91 
Zambia 127.95 2,414.67 44.00 625.18 36.66 2.82 
 
Source of Data: WHO Global Health Expenditure database. 
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The results from the country-by-country ADF tests should be taken with caution.   The 
shortness of the time dimension of the data, together with the inclusion of a time trend in the 
augmented regression would cause the ADF test to have low power in this instance.    I therefore 
also ran the IPS panel unit root test, which is supposed to provide increased power as the cross 
sectional dimension of the data increases.  The result from the IPS test conforms with the ADF 
results for both the GDP and total healthcare series.  This provides additional evidence that both 
series have unit roots. 
6.3 Results from Cointegration Tests 
Table 6.3 below presents test statistics from the Engle-Granger country by country tests for 
cointegration.  The critical values for the test, as tabulated in MacKinnon (1990, 2010) are -5.432, 
-4.422 and -3.963 for the 1%, 5% and 10% significance levels respectively.  The null of no 
cointegration can be rejected for just 7 of the 44 countries in the sample at a 5% significance level.  
At the 10% significance level, the null can be rejected for just 5 countries.  The results therefore 
provide overwhelming evidence against the existence of a long relationship between total 
healthcare expenditures per capita and GDP per capita.  This conforms with some existing studies, 
but as mentioned above, the results must be viewed with suspicion due to the low power of the test 
in this study. 
 6.4 Results from Model Estimation 
On the basis of the results from the unit root tests I enter total health care expenditures and 
GDP per capita as first differences in all regressions.  I estimate eight models of the relationship 
between total health care expenditures and gross domestic product per capita.  Model 1 is the 
GMM estimate as explained in chapter 5, where the model is estimated without an intercept.  
Model 2 adds an intercept to the equation in Model 1.  Model 3 and Model 4 are the  
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Table 6.2 
Country-by-country ADF Tests and Panel IPS Test 
 
 lGDPpc  lTHEpc_PPP 
COUNTRY t-stat p-value   t-stat p-value  
Angola -3.584 0.0312 I(0)  -4.934 0.0003 I(0) 
Benin -1.964 0.6209 I(1)  -3.632 0.0273 I(0) 
Botswana -4.313 0.0030 I(0)  -3.369 0.0557 I(1) 
Burkina Faso -3.460 0.0439 I(0)  -0.846 0.9616 I(1) 
Burundi -1.588 0.7970 I(1)  -1.950 0.6282 I(1) 
Cameroon -2.149 0.5183 I(1)  -7.243 0.0000 I(0) 
Cape Verde -2.455 0.3507 I(1)  -2.363 0.3996 I(1) 
CAR -0.422 0.9862 I(1)  -4.301 0.0031 I(0) 
Chad -2.293 0.4380 I(1)  -2.148 0.5192 I(1) 
Comoros -1.550 0.8113 I(1)  -1.995 0.6044 I(1) 
Congo -2.178 0.5025 I(1)  -1.810 0.7001 I(1) 
Cote D'Ivoire -2.876 0.1703 I(1)  -1.156 0.9190 I(1) 
DRC -2.388 0.3859 I(1)  -2.167 0.5084 I(1) 
Djibouti -2.193 0.4939 I(1)  -2.860 0.1758 I(1) 
Egypt -2.365 0.3982 I(1)  -3.233 0.0781 I(1) 
Eq. Guinea -2.750 0.2158 I(1)  -3.048 0.1192 I(1) 
Ethiopia -1.438 0.8494 I(1)  -1.294 0.8895 I(1) 
Gabon -1.485 0.8341 I(1)  -3.356 0.0576 I(1) 
Gambia -2.841 0.1823 I(1)  -2.207 0.4861 I(1) 
Ghana -2.116 0.5372 I(1)  -3.590 0.0307 I(0) 
Guinea -0.731 0.9710 I(1)  -1.602 0.7916 I(1) 
Guinea-Bissau -2.998 0.1326 I(1)  -2.279 0.4458 I(1) 
Kenya -1.774 0.7174 I(1)  -3.361 0.0568 I(1) 
Lesotho -0.676 0.9747 I(1)  -0.713 0.9723 I(1) 
Madagascar -2.282 0.4438 I(1)  -1.837 0.6869 I(1) 
Malawi -2.713 0.2308 I(1)  -1.981 0.6116 I(1) 
Mali -2.692 0.2394 I(1)  -4.909 0.0003 I(0) 
Mauritania -2.681 0.2441 I(1)  -3.186 0.0873 I(1) 
Mauritius -2.645 0.2597 I(1)  -3.664 0.0249 I(0) 
Morocco -2.561 0.2983 I(1)  -3.127 0.1000 I(1) 
Namibia -2.267 0.4524 I(1)  -1.245 0.9010 I(1) 
Niger -1.627 0.7818 I(1)  -2.980 0.1378 I(1) 
Nigeria -1.329 0.8806 I(1)  -1.822 0.6940 I(1) 
Rwanda -2.346 0.4084 I(1)  -1.691 0.7547 I(1) 
Sao Tome -1.775 0.7165 I(1)  -2.842 0.1820 I(1) 
Senegal -1.386 0.8649 I(1)  -0.211 0.9913 I(1) 
Seychelles -3.122 0.1010 I(1)  -2.576 0.2909 I(1) 
Swaziland -1.334 0.8791 I(1)  -1.495 0.8309 I(1) 
Togo -1.222 0.9060 I(1)  -1.757 0.7253 I(1) 
Tunisia -0.015 0.9941 I(1)  -2.795 0.1989 I(1) 
Tanzania -4.026 0.0081 I(0)  -2.226 0.4754 I(1) 
Zambia -2.311 0.4279 I(1)  -2.645 0.2597 I(1) 
        
IPS -1.2694 0.1021 I(1)  -0.2994 0.3823 I(1) 
 
The 1%, 5% and 10% critical values of the ADF distribution are -4.38, -3.60 and -3.24.  The tests were run with a trend 
and no lags.   
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 Table 6.3 
 
 
 
 
 
 
 
 
 
 
Test for Cointegration 
The 1%, 5% and 10% critical values are -5.432, -4.442 and -3.963.  A linear trend is included in the first 
stage regression.  No lag differences are included in the second stage regression. 
COUNTRY Z(t) 
Angola -5.664 
Benin -3.881 
Botswana -3.653 
Burkina Faso -1.165 
Burundi -1.814 
Cameroon -6.243 
Cape Verde -3.132 
CAR -4.867 
Chad -2.300 
Comoros -2.458 
Congo -3.211 
Cote D'Ivoire -1.707 
DRC -3.982 
Djibouti -2.561 
Egypt -3.295 
Eq. Guinea -3.560 
Ethiopia -2.022 
Gabon -4.491 
Gambia -2.645 
Ghana -3.323 
Guinea -1.866 
	
COUNTRY Z(t) 
Guinea-Bissau -2.875 
Kenya -4.479 
Lesotho -4.381 
Madagascar -2.885 
Malawi -2.287 
Mali -4.766 
Mauritania -4.023 
Mauritius -3.719 
Morocco -3.369 
Namibia -1.417 
Niger -3.089 
Nigeria -4.899 
Rwanda -3.628 
Sao Tome -2.783 
Senegal -2.295 
Seychelles -2.745 
Swaziland -2.135 
Togo -3.590 
Tunisia -2.819 
Tanzania -3.285 
Zambia -3.836 
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fixed effects and random effects estimates respectively.  These estimates have been used in 
previous studies and are included here for comparison purposes.  Models 1 through 4 assume that 
all explanatory variables are exogenous, and are estimated without instrumental variables.  Models 
5 through 8 are as described for Models 1 through 4, except that GDP per capita is endogenous 
and is instrumented in the estimation procedures.  In all models the dependent variable is the log 
of total health care expenditures per capita, measured at purchasing power parity.  The explanatory 
variable of interest is the log of GDP per capita.  I include as controls  
variables that are available and have been found in previous studies to be useful for explaining 
total health care expenditures.  All variables are entered as log first differences: 
THEpc_PPP total healthcare expenditures per capita 
 
GDPpc      Gross Domestic Product per capita 
tb tuberculosis prevalence, measured as the number of cases/thousand 
 
urb   the percent of urbanization among the population 
O65_   the percentage of the population above age 65 years 
GGHE_THE General government health expenditures as a share of total health care 
expenditures. 
 
Table 6.4 presents estimates of the four models where all variables are treated as 
exogenous, and therefore no instrumental variables are used.  An assumption made earlier in this 
paper is that health care spending and GDP are jointly determined in a system of simultaneous 
equations.  The estimates in Table 6.4, when compared to estimates that correct for possible 
endogeneity due to simultaneity bias, would shed light as to the size of any bias in the coefficient 
estimates.  In Model 1 all the explanatory variables are statistically different from zero at all 
significant levels except for the percentage of the population above sixty-five, which is 
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insignificant at all levels.  The coefficient on the tuberculosis prevalence rate has a counterfactual 
sign.  Taken at face value, the negative sign indicates that total spending on health  
care declines as the TB prevalence rises, contrary to what would be expected.  The coefficient 
estimate on GDP is highly significant and of the expected sign.  It implies an elasticity of 0.73, 
which is less than 1.  The percentage of urban population in total population and the share of 
government spending on health care in total health care spending are both significant and of the 
expected sign.  When an intercept is added in Model 2, GDP, urbanization and the government 
spending share remain significant and of the expected sign.  The TB coefficient is still negative, 
and significant at the 10 and 5 percent levels, but insignificant at the 1 percent level.  The 
population over 65 variable becomes significant but has the unexpected sign.  In Model 3, the TB, 
urbanization and population over 65 variables are all insignificant at all levels, and of the wrong 
sign.  The GDP and government share variables remain significant and of the expected sign.  In 
Model 4, the GDP and urbanization variables remain significant and of the expected sign, but all 
other variables are insignificant. The encouraging feature of Table 6.4 is that in all models, the 
GDP variable is highly significant.  The estimated elasticity is less than 1, and the 95 percent 
confidence interval lies entirely below 1 in the GMM models. 
Table 6.5 presents coefficient estimates when GDP is treated as endogenous and 
instrumental variables are used to obtain consistent estimates.  Model 5 presents results from a 16-
equation GMM estimation model without intercept, as presented in Section 5.3 earlier.  The GDP, 
urbanization and government share variables are all highly significant and of the expected sign.  
The GDP elasticity of health care spending is 0.71.  This is less than 0.73, the elasticity estimated 
in Model 1, but the difference is statistically insignificant.  The 99, 95 and 90 percent confidence 
intervals for the coefficient estimate of GDP per capita in Model 5 all enclose 0.73,    
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the estimate in Model 1.  This analysis therefore does not provide strong evidence that for the 
sample of countries in this study, income and health care spending are simultaneously determined.  
This conclusion changes however when results from the fixed and random effects estimation are 
examined. 
The TB variable in Model 5 continues to be only marginally significant, and of the wrong 
sign.  The population over 65 share is insignificant, as in Model 1, though of the expected sign.  In 
Model 6, all variables are statistically significant, although the TB coefficient continues to be 
negative.  The estimated income elasticity of health care spending rises significantly in Models 7 
and 8, to 0.83 and 0.87 respectively.  These are well outside of the widest confidence interval of 
Table 6.4 
Coefficient Estimates without use of Instrumental Variables 
 
 Model 1 Model 2 Model 3 Model 4 
 coeff. z-stat coeff. z-stat coeff. z-stat coeff. z-stat 
Intercept - -  
-0.1000 
(0.0195) -5.12 
 
-0.0199 
(0.0263) 
-0.76 0.0093 (0.0142) 0.65 
lGDPpc 0.7265 (0.0114) 63.88 
0.6880 
(0.0369) 8.66 
0.6701 
(0.1504) 4.45 
0.6879 
(0.1278) 5.38 
tb -0.0417 (0.0133) -3.17 
-0.1452 
(0.0677) -2.15 
-0.0004 
(0.0231) -0.02 
-0.0169 
(0.0243 -0.70 
urb 1.4675 (0.1643) 16.17 
10.8143 
(1.5715) 6.88 
-0.4059 
(0.7984) -0.51 
0.4468 
(0.1926) 2.32 
O65_ 0.7028 (0.4881) 1.44 
-1.2544 
(0.4282) -2.93 
-0.0902 
(0.5544) -0.16 
0.2044 
(0.3937) 0.52 
GGHE_THE 0.2609 (0.120) 21.76 
0.2903 
(0.0099) 29.20 
0.0013 
(0.0005) 2.88 
0.0005 
(0.0003) 1.42 
Hansen’s J  33.33 (p=0.64)  
36.16 
(p=0.46)     
 
Dependent variable: First difference of the log of total health care expenditures per capita.  All variables are entered as log 
first differences. 
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the estimate in Model 5, and also significantly higher than the estimates when GDP is treated as 
exogenous in Model 3 and Model 4, 0.67 and 0.69 respectively.  Thus, in the fixed and random 
effects models, the estimates of the income elasticity rise by 24 and 28 percent respectively when 
GDP per capita is treated as endogenous and its effect is estimated using instrumental variables.  
This observation runs counter to the findings when the GMM estimation procedure is used, and 
provides some evidence that GDP per capita is endogenous in the total health care expenditure 
equation.  The endogeneity, when not taken into account, introduces a downward bias in 
coefficient estimates of the effect of GDP on total health care spending.   
The source of the discrepancy in the results on the possible endogeneity of GDP per capita 
in the health care spending equation is not well understood in this study, and should be a subject 
for future study.  I note however two facts in support of the findings from the GMM procedure.  
Table 6.5 
Coefficient Estimates with Instrumental Variables 
 Model 5 Model 6 Model 7 Model 8 
 coeff. z-stat coeff. z-stat coeff. z-stat coeff. z-stat 
Intercept - - - 
-0.0689 
(0.0112) -6.16 
-0.0304 
(0.0835) -0.36 
0.0133 
(0.0141) 0.94 
lGDPpc 0.7087 (0.0258) 27.42 
0.7453 
(0.0424) 17.57 
0.8280 
(0.2983) 2.78 
0.8677 
(0 .2387) 3.64 
tb -0.0256 (0.0136) -1.88 
-0.1360 
(0.0475) -2.86 
0.0023 
(0.0215) 0.11 
-0.0157 
(0.0241) -0.65 
urb 2.5234 (0.1733) 16.17 
8.3042 
(0.9157) 9.07 
-0.4268 
(0.8027) -0.53 
0.4484 
(0.1825) 2.46 
O65_ 0.3357 (0.3814) 0.88 
-0.1273 
(0.4379) -0.29 
-0.0975 
(0.5322) -0.18 
0.2417 
(0.3912) 0.62 
GGHE_THE 0.2258 (0.034) 16.89 
0.2685 
(0.0115) 23.33 
0.0013 
(0.0005) 2.79 
0.0003 
(0.0004) 0.88 
Hansen’s J  38.95 (p=0.38)  
30.44 
(p=0.73)     
 
Dependent variable: First difference of the log of total health care expenditures per capita.  All variables are entered as log 
First differences. 
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First, the GMM estimates are more precisely estimated, as is evidenced from their smaller standard 
errors.  On the other hand, the fixed and random effects estimates have confidence intervals that 
are very wide and encompass a wide range of possible estimates of the income elasticity.  
Endogeneity affects the unbiasedness of the coefficient estimates, not their efficiency.  As all the 
estimation procedures were set up to be robust to various forms of heteroscedasticity and serial 
correlation, the greater efficiency of the GMM procedure provides more confidence in its 
estimates.  Secondly, the Hansen J test of overidentifying assumptions show that the GMM models 
are well specified.  These two taken together provide stronger evidence in favor of the estimates 
from the GMM procedures. 
As this study has as its primary purpose estimating the size of the income elasticity of 
health care spending, the results indicate that in the sample of countries under study, GDP per 
capita has a significant impact on aggregate health care spending per capita, and that the income 
elasticity is less than 1.  In the most preferred model, even the 99 percent confidence interval lies 
entirely below 1.  
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CHAPTER 7 CONCLUSION 
 This study is an attempt to contribute to the growing literature on the determinants of health 
care spending, particularly as it relates to the role of GDP per capita and the size of the income 
effect.  A number of findings from the study could potentially be useful for fostering the ongoing 
debate that has accompanied this body of research. 
 The main finding from the study is that for the sample of countries and the time frame 
covered, GDP per capita plays a significant role in determining total spending on health care for a 
country.  Of the five possible determinants of health care spending considered in this study, GDP 
per capita had the most significant influence, and its effect was the most robust across various 
specifications, a finding that accords well with evidence from the existing literature.  Contrary to 
the dominant view from this literature, the income elasticity of health care spending was found to 
be significantly less than 1.  Newhouse (1977) had speculated on health care as a luxury good 
based on his finding of an income elasticity significantly greater than 1.  He proposed two 
implications of his findings, that health care spending at the margin buys “caring” rather than 
“curing”, and that countries choose the system of health care delivery on the basis of their wealth. 
 One way to interpret the findings in this study in light of the implications of Newhouse 
(1977) is to note that health care is not a homogenous commodity.  Some components of health 
care produce improvements in physiological health, and there are elements of that have more to 
do with the subjective components that do not necessarily reduce morbidity or mortality. Countries 
may choose not just the system of delivery, but more crucially the mix of products and services 
according to their wealth.  Indeed, a careful observation of health care systems would show that 
there is a higher concentration of advanced medical technology and nursing care for the elderly in 
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wealthy economies than in the poor economies of Africa, where medical technology is rudimentary 
and elder care is largely informal.   
 Presumably all countries choose care that improve physiological health.  It is conceivable, 
however, that beyond a certain level of achievement of health status, spending on the subjective 
components become more important.  Health outcomes in much of Africa are so poor as to impact 
not just upon the physical comfort and wellbeing of individuals, but to also pose impediments to 
socio-economic development.  These societies may therefore choose a healthcare mix that delivers 
the biggest gains for the dollars spent.  In such cases, the marginal dollar spent on healthcare may 
well improve morbidity and mortality.  Improvements in health outcomes accumulate, however, 
and as health status become favorable societies may opt for more of the components of health care 
that have little to do with improving health outcomes.  It might be the case that the marginal 
healthcare dollar buys quite a different product in Africa than it does in wealthier countries, and 
income has much to do with the determination this allocation.  It would therefore not be surprising 
to find that healthcare is a necessity in Africa but a luxury in wealthier countries. 
 The findings on stationarity of healthcare spending and GDP support the prevailing view 
in the literature.  These findings buttress the criticism by Hanson and King (1996) of studies that 
that use the levels of these variables in time series and pooled regressions.  Accordingly, 
researchers using these variables in their studies should enter them as differences rather than in 
levels. 
 The issue of whether health care spending and GDP are cointegrated is yet unsettled in the 
literature, and results from this study do little to provide clarity.  While it is plausible that 
healthcare spending and GDP should have a long term relationship, this study finds contrary 
evidence.  This may, however, have more to do with the data than underlying theory, as the 
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shortness of the time series in this study does not allow for the making of strong statements on 
time series analysis.  It is hoped that more clarity on this issue would come from future studies as 
longer time series become available. 
 Finally, on the assumption made in this study of possible endogeneity of GDP in the 
healthcare spending equation, the findings provide weak evidence of no such endogeneity issues.  
In the preferred GMM estimation procedures used, no evidence was found of bias in the coefficient 
estimate of GDP per capita.  However, this runs counter to findings from fixed and random effects 
models estimated in the study, which found some evidence of downward bias.  These models 
appeared to be less efficiently estimated than the GMM models, which allowed them to accept a 
much wider range of possible values of the income elasticity of health care spending.   I am 
therefore more inclined to conclude that no evidence of endogeneity was found in this study on 
the basis of the results from the GMM procedure. 
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Degree:  Doctor of Philosophy 
 In this essay I estimate the elasticity of total healthcare expenditures with respect to gross 
domestic product.  I also address the stationary properties of total healthcare expenditures and 
gross domestic product, and whether these measures are cointegrated.  The empirical exercise uses 
a sample of African countries so that the estimates can be compared to those that have been made 
using data on OECD countries.  To address the issue of possible endogeneity of GDP in the 
healthcare expenditure equation, I assume that total healthcare expenditures and gross domestic 
product are simultaneously determined, and using structural equations, I identify instrumental 
variables for GDP in the estimation equation. 
 I find that the income elasticity of healthcare expenditures is significantly less than 1, 
contrary to studies on OECD countries that have found elasticities at or greater than 1.  I confirm 
that both healthcare expenditure and GDP are nonstationary, and find that these variables are not 
cointegrated.  I decline to make definitive statements on the issue of cointegration because of the 
short time series I use in the study.  On the basis of my findings I note that health care is not 
		
47	
homogenous, and I speculate that Africans choose a mix of healthcare products that actually reduce 
morbidity and mortality, which makes healthcare a necessity.  This is in contrast to the OECD 
countries, where the mix of health care products has a high concentration of medical technology 
and advance medicines that confer clinical or psychological benefits that have little to do with 
improving physiological health, and hence is a luxury as has been found in previous studies. 
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